HOME
ABOUT US
Company Profile
Management Team
History & Awards
Contact Us
PRODUCTS & R&D
R&D Platform
Pipeline
Cooperation
NEWS
Company News
Media Reports
INVESTOR
Reports
Stock Info
Contact
TALENTS
Careers
News Center
Media coverage
Jiangsu Science and Technology Daily, Maker Weekly – Feature: Yu Qiang: No "Old" Remedies, No Shortcuts—Focusing Steadfastly on Developing a First-Generation Chinese Diabetes Drug
Chatty and quick-talking, with a knack for articulating insights on management and financing, Yu Qiang, founder and CEO of Shengshi Taikang Biopharmaceutical Technology Co., Ltd., seems to possess entrepreneurial talent far beyond that of most R&D-driven entrepreneurs. In fact, from his undergraduate studies all the way through his postdoctoral research, he remained deeply committed to scientific inquiry—until a certain forum finally "activated his entrepreneurial instincts," prompting him to take the leap into the world of startup entrepreneurship. Since then, he’s been wearing multiple hats simultaneously: steering the company’s management, driving innovation in R&D, and shaping its strategic direction—ultimately carving out a significant niche in China’s burgeoning landscape of domestically developed pharmaceuticals.
Time:2018-11-13 10:21
Dr. Yu Qiang Shares Insights in an Interview with Suzhou Daily: "My 'Mortise-and-Tenon Pact' with the Industrial Park"
On August 10, the "Extraordinary Park Edition" of the Suzhou Daily featured a special report titled "Celebrating 40 Years of Reform and Opening-Up — My Story with the Park," which highlighted the "Mortise-and-Tenon Pact" between Dr. Yu Qiang, Founder and CEO of Shengshi Taike, and Suzhou Industrial Park.
Time:2018-08-10 10:21